← Evidence map

ArticleLeukemia2017

EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia.

S Charmsaz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

26 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27922598